Listed in Fortune 500, Healthcare
About
DaVita Inc. provides kidney dialysis services through a network of 2,664 outpatient dialysis centers in the United States, serving 202,700 patients, and 241 outpatient dialysis centers in other countries. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives. The company has a 37% market share in the dialysis market. It is organized in Delaware and based in Denver.[2] In 2018, 69% of the company’s revenues came from Medicare and other government-based health insurance programs. In 2018, 89.6% of the company’s patients were covered by government-based health insurance programs. Commercial payers, which accounted for 31% of revenues in 2018, generate all of the company’s profit as they reimburse at a much higher rate than government-based health insurance programs.[2] The company is ranked 188th on the 2019 Fortune 500.[3] The name “DaVita” is derived from the Italian language phrase “Dare Vita”, which means “giving life”.[4] Berkshire Hathaway owns 23% of the company.
Contact
-
2000 16Th Street
80202 - https://www.davita.com/